September 24, 2026

Review highlights how altered metabolism drives kidney cancer growth – News-Medical

September 24, 2026

FDA Approves Belzutifan Plus Lenvatinib for Advanced Kidney Cancer – Oncology News Central

September 24, 2026

FDA Approves Welireg Plus Lenvima for Advanced Kidney Cancer After Immunotherapy – Cure Today

September 24, 2026

FDA clears Welireg, Lenvima for post-immunotherapy kidney cancer – FirstWord Pharma

September 21, 2026

Proven radiotracer highly effective in detecting rare, aggressive kidney cancer – Medical Xpress